Pfizer Inc. v. Sun Pharmaceutical Industries Limited - 1:26-cv-01270

Pfizer Inc. v. Sun Pharmaceutical Industries Limited (Case No. 1:26-cv-01270), filed on Oct 1, 2026 in the District Court, D. Delaware involving patent infringement. This case involves patent infringement claims between the parties. Explore details about the litigants, key filings, and major docket updates.

Case Details

Case Number
1:26-cv-01270
Filing Date
Oct 1, 2026
Cause of Action
Patent Infringement
Status
-
Court
District Court, D. Delaware
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

Parties Involved

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Pfizer Inc. -
Sun Pharmaceutical Industries Limited -

Patents Involved

This case involves 4 patents, each of which is central to the dispute. These patents may be subject to claims of infringement, challenges to their validity, or other issues concerning their scope and enforcement.

Application NumberPatent Number
-US8680111B2
-US11020376B2
-US10420749B2
-US11299500B2

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Oct 1, 2026Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (slk) (Entered: 10/02/2026)PACER Document
Oct 1, 2026COMPLAINT for Patent Infringement and Declaratory Judgment of Patent Infringement against Sun Pharmaceutical Industries Limited (Filing fee $ 405, receipt number ADEDC-5080297) - filed by Pfizer Ireland PFE Holding 1 LLC, Pfizer Asia Manufacturing Pte Ltd, PF PRISM Holdings B.V., Pfizer Inc., Pfizer Ireland Pharmaceuticals Unlimited Company, PF PRISM IMB B.V.. (Attachments: # 1 Exhibits A-E, # 2 Civil Cover Sheet)(slk) (Entered: 10/02/2026)PACER Document
Oct 2, 2026Summons Issued as to Sun Pharmaceutical Industries Limited on 10/2/2026. (slk) (Entered: 10/02/2026)PACER Document
Oct 1, 2026Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Pfizer Inc. for PF PRISM Holdings B.V., PF PRISM IMB B.V., Pfizer Asia Manufacturing Pte Ltd, Pfizer Ireland PFE Holding 1 LLC, and Pfizer Ireland Pharmaceuticals Unlimited Company, filed by PF PRISM Holdings B.V., PF PRISM IMB B.V., Pfizer Asia Manufacturing Pte Ltd, Pfizer Inc., Pfizer Ireland PFE Holding 1 LLC, Pfizer Ireland Pharmaceuticals Unlimited Company. (slk) (Entered: 10/02/2026)PACER Document
Oct 1, 2026Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,680,111 B2; 10,420,749 B2; 11,020,376 B2; 11,299,500 B2. (slk) (Entered: 10/02/2026)PACER Document
Oct 1, 2026Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: August 18, 2026. Date of Expiration of Patent: U.S. Patent No. 8,680,111 expires on March 5, 2033, U.S. Patent Nos. 10,420,749 and 11,020,376 expire on July 27, 2036, and U.S. Patent No. 11,299,500 on October 4, 2038.Thirty Month Stay Deadline: 2/18/2029. (slk) (Entered: 10/02/2026)PACER Document
Oct 1, 2026COMPLAINT for Patent Infringement and Declaratory Judgment of Patent Infringement against Sun Pharmaceutical Industries Limited (Filing fee $ 405, receipt number ADEDC-5080297) - filed by Pfizer Ireland PFE Holding 1 LLC, Pfizer Asia Manufacturing Pte Ltd, PF PRISM Holdings B.V., Pfizer Inc., Pfizer Ireland Pharmaceuticals Unlimited Company, PF PRISM IMB B.V.. (Attachments: # 1 Exhibits A-E, # 2 Civil Cover Sheet)(slk) (Entered: 10/02/2026)Attachment
Oct 1, 2026COMPLAINT for Patent Infringement and Declaratory Judgment of Patent Infringement against Sun Pharmaceutical Industries Limited (Filing fee $ 405, receipt number ADEDC-5080297) - filed by Pfizer Ireland PFE Holding 1 LLC, Pfizer Asia Manufacturing Pte Ltd, PF PRISM Holdings B.V., Pfizer Inc., Pfizer Ireland Pharmaceuticals Unlimited Company, PF PRISM IMB B.V.. (Attachments: # 1 Exhibits A-E, # 2 Civil Cover Sheet)(slk) (Entered: 10/02/2026)Attachment